2010 Scrip 100 - Can China retain its API sourcing appeal?
09 December 2009
Robert Kennedy
China has a burgeoning API manufacturing base, albeit one focused largely on achieving quick profits in the domestic sector. Robert Kennedy's analysis reveals a striking number of Chinese companies that are gearing up to supply pharmaceutical ingredients to the regulated markets of the west....
Please Login to read the full article.
09 December 2009
Robert Kennedy
Please Login to read the full article.
RELATED CONTENT
NEWS
- Chinese JV to move Pfizer deeper into emerging market generics
- Asia Beat: Takeda + Nycomed = panic buy or strategic masterstroke?
- Two Chinese alliances for Amerigen as it pursues branded generics opportunities
- China's Huahai spots bulk manufacturing opportunities amid upcoming patent expiries
COMMENT
Other Informa Comment
EVENTS
09 February 2012
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
